ohm: You're joking, right? You're tolerant of the prior FDA's CD12 decision to protect covid critical patients from a 3rd and 4th dose of LL because it was based on a simple "misunderstanding of leronlimab" by "those who have some understanding of science."

I don't claim any meaningful understanding of science, but I can do simple math. If a drug with a 10 day half life is administered on day 0 and day 7, a decision to evaluate the efficacy of that drug on day 28, instead of day 14, demonstrates no understanding of either 2nd grade math or science.